Desvenlafaxine Completed Phase 2 Trials for Depression / Major Depressive Disorder (MDD)

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00619619Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder